Skip to main content
    I

    Illumina Inc (ILMN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $198.00
    -9.01 (-4.35%)

    Market Cap: $31.30B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Illumina Inc (ILMN) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Illumina (ILMN) trades at 37.7x trailing earnings and 6.6x sales. Its P/E of 37.7x is below its 5-year median of 58.1x. Its forward P/E is 33.6x. The median P/E across 11 similar companies is 26.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 12.2% higher over the next year. Its free cash flow yield is 3.5%.

    MultipleValue
    P/E (trailing)37.7x
    Forward P/E33.6x
    Price to sales6.6x
    Price to book9.5x
    EV/EBITDA21.8x
    Price to FCF28.3x
    EV/FCF28.8x
    PEG2.5
    FCF yield3.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 33.5% below 56.7x, its P/S is 35.9% below 10.3x and its P/B is in line.

    MultipleCurrent5-year median10-year median
    P/E37.7x58.1x56.7x
    P/S6.6x5.2x10.3x
    P/B9.5x5.3x9.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 27.0x in 2025 to 160.0x in 2023. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$131.1627.0x4.7x7.4x
    2024$133.6354.5x4.9x9.0x
    2023$139.24160.0x4.9x3.9x
    2022$202.2095.4x6.9x4.8x
    2021$380.4463.8x12.6x5.6x
    2020$370.0082.2x16.8x11.6x
    2019$331.7450.4x13.8x10.6x
    2018$299.9352.4x13.3x11.6x
    2017$218.4954.5x11.6x11.4x
    2016$128.0437.8x7.9x8.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ILMN

    What is ILMN's forward P/E ratio?

    Illumina has a forward P/E ratio of 33.6x.

    Is ILMN stock overvalued?

    GNG's valuation label for ILMN is Fairly valued. Its P/E of 37.7x compares with a median of 26.8x across 11 similar companies.

    What is ILMN's price to sales ratio?

    Illumina has a price to sales ratio of 6.6x.

    What is Illumina's average P/E ratio over 5 years?

    Illumina's median P/E over the last 5 years is 58.1x, from 60 month-end values through Oct 2026.

    What is ILMN's PEG ratio?

    Illumina has a PEG ratio of 2.5.